APA (7th ed.) Citation

Song H, Tang X, Li X, Wang Y, Deng A, Wang W, . . . Wu LQ. (2020). HLJ2 Effectively Ameliorates Colitis-Associated Cancer via Inhibition of NF-κB and Epithelial–Mesenchymal Transition. Dove Medical Press.

Chicago Style (17th ed.) Citation

Song H, Tang X, Li X, Wang Y, Deng A, Wang W, Zhang H, Qin H, and Wu LQ. HLJ2 Effectively Ameliorates Colitis-Associated Cancer via Inhibition of NF-κB and Epithelial–Mesenchymal Transition. Dove Medical Press, 2020.

MLA (9th ed.) Citation

Song H, et al. HLJ2 Effectively Ameliorates Colitis-Associated Cancer via Inhibition of NF-κB and Epithelial–Mesenchymal Transition. Dove Medical Press, 2020.